Exablate
Payments companies reported to CMS as associated with Exablate. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Exablate, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Exablate
These are the largest totals companies reported as associated with Exablate. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Hanane Chaibainou | Westampton, NJ | Acute Care (Nurse Practitioner) | $10,702.54 |
| Kanwalcharan Sahni | Richmond, VA | Neurological Surgery | $7,754.19 |
| Jason Schwalb | Detroit, MI | Neurological Surgery | $5,269.88 |
| H Wilkins | Sellersville, PA | Family Medicine | $5,000.00 |
| Tara Kimbason | Norfolk, VA | Neurology (Psychiatry & Neurology) | $4,976.93 |
| Justin Martello | Newark, DE | Neurology (Psychiatry & Neurology) | $4,753.69 |
| Francisco Ponce | Phoenix, AZ | Neurological Surgery | $4,672.49 |
| Zachary Levine | Bethesda, MD | Neurological Surgery | $4,498.09 |
| Albert Fenoy | Humble, TX | Neurological Surgery | $4,463.09 |
| Mark Hoeprich | Kettering, OH | Neurological Surgery | $4,409.59 |
Prescribed Exablate?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.